The Addition of Paclitaxel to Doxorubicin and Cisplatin and Volume-Directed Radiation Does Not Improve Overall Survival (Os) or Long-Term Recurrence-Free Survival (Rfs) in Advanced Endometrial Cancer (Ec): A Randomized Phase Iii Nrg/Gynecologic Oncology Group (Gog) Study
AuthID
P-00V-T7G
P-00V-T7G